Neuroimmunomodulation
Original Paper
Differential Expression of Extracellular Matrix and Adhesion Molecule Genes in the Brain of Juvenile versus Adult Mice in Responses to Intracerebroventricular Administration of IL-1Ching S. · Zhang H. · Chen Q. · Quan N.Department of Oral Biology, Ohio State University, Columbus, Ohio, USA
|
|
Neuroimmunomodulation 2007;14:46–56
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
First-Page Preview
Received: December 10, 2006
Accepted: March 01, 2007
Published online: August 15, 2007
Issue release date: August 2007
Number of Print Pages: 11
Number of Figures: 4
Number of Tables: 3
ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)
For additional information: https://www.karger.com/NIM
Abstract
Objective: Intracerebroventricular (ICV) injection of interleukin-1 (IL-1) stimulates the recruitment of leukocytes into the central nervous system at different time points in juvenile versus adult mice. Our results showed that leukocytes entered brain parenchyma at 8 and 16 h after injection in juvenile and adult mice, respectively. This study compares the differential gene expression patterns of extracellular matrix and adhesion molecules in the brain of juvenile and adult mice. Methods: We analyzed these gene expressions in mice brains by microarray and real-time PCR at 2 and 8 h after ICV IL-1. Results: After ICV IL-1, the following genes were significantly upregulated in both juvenile and adult mice: LAMβ1-1, MMP17, TGFβ, THBS3 and VCAM1 were upregulated at 2 h after injection; LAMβ1-1 and TGFβ were upregulated at 8 h. Additional changes were found in adult mice only: CNTN1, ECM1, ICAM1 and LAMα4 were upregulated at 2 h after injection; COL4α1, MMP3 and VCAM1 were upregulated at 8 h; TIMP4 was downregulated. Comparing juvenile and adult mice, real-time PCR analysis showed that there was more induction of TGFβ at 8 h and a stronger downregulation of TIMP4 at 2 h after injection in juvenile mice. Higher expression of MMP17 was found in juvenile mice, compared to adult mice, at both 2 and 8 h after injection. Conclusions: These data show distinct expression patterns of molecules related to the extracellular matrix and adhesion molecules in juvenile versus adult mice, and suggest that increased expression of MMP17 and TGFβ and decreased expression of TIMP4 may contribute to the accelerated recruitment of leukocytes into the central nervous system in juvenile animals.
© 2007 S. Karger AG, Basel
Related Articles:
References
- McKeating EG, Andrews PJ: Cytokines and adhesion molecules in acute brain injury. Br J Anaesth 1998;80:77–84.
- McKeating EG, Andrews PJ, Mascia L: Leukocyte adhesion molecule profiles and outcome after traumatic brain injury. Acta Neurochir Suppl 1998;71:200–202.
- Schiffenbauer J, Streit WJ, Butfiloski E, LaBow M, Edwards C 3rd, Moldawer LL: The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin Immunol 2000;95:117–123.
- Ostergaard C, Yieng-Kow RV, Benfield T, Frimodt-Moller N, Espersen F, Lundgren JD: Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun 2000;68:3153–3157.
- Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE: The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 2000;165:2327–2330.
- Patterson CE, Lawrence DM, Echols LA, Rall GF: Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and γ interferon dependent. J Virol 2002;76:4497–4506.
- Bernardes-Silva M, Anthony DC, Issekutz AC, Perry VH: Recruitment of neutrophils across the blood-brain barrier: the role of E- and P-selectins. J Cereb Blood Flow Metab 2001;21:1115–1124.
- Proescholdt MG, Chakravarty S, Foster JA, Foti SB, Briley EM, Herkenham M: Intracerebroventricular but not intravenous interleukin-1β induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 2002;112:731–749.
- Ching S, He L, Lai W, Quan N: IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 2005;19:127–137.
- Ching S, Zhang H, Lai W, Quan N: Peripheral injection of lipopolysaccharide prevents brain recruitment of leukocytes induced by central injection of interleukin-1. Neuroscience 2006;137:717–726.
- Abbott NJ: Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000;20:131–147.
- Quan N, Herkenham M: Connecting cytokines and brain: a review of current issues. Histol Histopathol 2002;17:273–288.
- Maslin CL, Kedzierska K, Webster NL, Muller WA, Crowe SM: Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection. Curr HIV Res 2005;3:303–317.
- Danton GH, Dietrich WD: Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 2003;62:127–136.
- Greenwood J, Etienne-Manneville S, Adamson P, Couraud PO: Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul Pharmacol 2002;38:315–322.
- Zameer A, Hoffman SA: Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J Neuroimmunol 2003;142:67–74.
- Dunne JL, Collins RG, Beaudet AL, Ballantyne CM, Ley K: Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-α-induced inflammation. J Immunol 2003;171:6105–6111.
- Ley K: Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002;186:8–18.
- Piraino PS, Yednock TA, Freedman SB, Messersmith EK, Pleiss MA, Karlik SJ: Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of α4 integrin. Mult Scler 2005;11:683–690.
- Danton GH, Dietrich WD: The search for neuroprotective strategies in stroke. AJNR Am J Neuroradiol 2004;25:181–194.
- Gasche Y, Soccal PM, Kanemitsu M, Copin JC: Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 2006;11:1289–1301.
- Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC: Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 2006;7:56.
- Shigemori Y, Katayama Y, Mori T, Maeda T, Kawamata T: Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir Suppl 2006;96:130–133.
- Vajtr D, Prusa R, Houst’ava L, Samal F, Kukacka J, Pachl J: Biochemical and immunohistochemical markers of brain injury (article in Czech). Soud Lek 2006;51:36–41.
- Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R: Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66:10357–10364.
- Gurney KJ, Estrada EY, Rosenberg GA: Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 2006;23:87–96.
- Boz C, Ozmenoglu M, Velioglu S, Kilinc K, Orem A, Alioglu Z, Altunayoglu V: Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon β. Clin Neurol Neurosurg 2006;108:124–128.
- Krizanac-Bengez L, Hossain M, Fazio V, Mayberg M, Janigro D: Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines. Am J Physiol Cell Physiol 2006;291:C740–749.
- Anthony DC, Bolton SJ, Fearn S, Perry VH: Age-related effects of interleukin-1β on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997;120:435–444.
- Bolton SJ, Perry VH: Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp Neurol 1998;154:231–240.
- Campbell SJ, Wilcockson DC, Butchart AG, Perry VH, Anthony DC: Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1β-induced neutrophil recruitment. J Neurochem 2002;83:432–441.
- Lawson LJ, Perry VH: The unique characteristics of inflammatory responses in mouse brain are acquired during postnatal development. Eur J Neurosci 1995;7:1584–1595.
- Goldring SR, Goldring MB: The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004;427(suppl):S27–36.
- Do MS, Jeong HS, Choi BH, Hunter L, Langley S, Pazmany L, Trayhurn P: Inflammatory gene expression patterns revealed by DNA microarray analysis in TNF-α-treated SGBS human adipocytes. Yonsei Med J 2006;47:729–736.
- Falk J, Bonnon C, Girault JA, Faivre-Sarrailh C: F3/contactin, a neuronal cell adhesion molecule implicated in axogenesis and myelination. Biol Cell 2002;94:327–334.
- Langle SL, Poulain DA, Theodosis DT: Neuronal-glial remodeling: a structural basis for neuronal-glial interactions in the adult hypothalamus. J Physiol Paris 2002;96:169–175.
- Bizzoca A, Virgintino D, Lorusso L, Buttiglione M, Yoshida L, Polizzi A, Tattoli M, Cagiano R, Rossi F, Kozlov S, Furley A, Gennarini G: Transgenic mice expressing F3/contactin from the TAG-1 promoter exhibit developmentally regulated changes in the differentiation of cerebellar neurons. Development 2003;130:29–43.
- De Benedictis L, Bizzoca A, Gennarini G: Transgenic models for studying expression and function of axonal adhesive glycoproteins. Arch Ital Biol 2005;143:179–190.
- De Benedictis L, Bizzoca A, Corsi P, Albieri I, Consalez GG, Gennarini G: Activation profile of the F3/Contactin gene in the developing mouse cerebellum. Mol Cell Neurosci 2006;32:403–418.
- Schiller M, Javelaud D, Mauviel A: TGF-β-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 2004;35:83–92.
- Bar-Or A, Nuttall RK, Duddy M, Alter A, Kim HJ, Ifergan I, Pennington CJ, Bourgoin P, Edwards DR, Yong VW: Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 2003;126:2738–2749.
- Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T: Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003;253:269–285.
- Kanesaka T, Mori M, Hattori T, Oki T, Kuwabara S: Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006;77:185–188.
- Gauthier MC, Racine C, Ferland C, Flamand N, Chakir J, Tremblay GM, Laviolette M: Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils. Int J Biochem Cell Biol 2003;35:1667–1673.
- Rahkonen OP, Koskivirta IM, Oksjoki SM, Jokinen E, Vuorio EI: Characterization of the murine Timp4 gene, localization within intron 5 of the synapsin 2 gene and tissue distribution of the mRNA. Biochim Biophys Acta 2002;1577:45–52.
Article / Publication Details
First-Page Preview
Received: December 10, 2006
Accepted: March 01, 2007
Published online: August 15, 2007
Issue release date: August 2007
Number of Print Pages: 11
Number of Figures: 4
Number of Tables: 3
ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)
For additional information: https://www.karger.com/NIM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
